SIM
ARNA

Strategic Investment Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Strategic Investment Management’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-2,414
Closed -$144K – 79
2013
Q4 		$144K Buy
+2,414
New +$126K 0.04% 59

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 17.47% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Strategic Investment Management's ARNA Position: Q1 2014 in Review

Strategic Investment Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2014, closing a stake of 2,414 shares — an estimated $144K sold.

Strategic Investment Management first reported a position in ARNA in Q4 2013 and held it in 1 quarter. The position peaked at $144K in Q4 2013. 131 funds tracked by Wall St. Rank hold ARNA as of Q1 2014.

  • Strategic Investment Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2014 after selling out during the quarter.
  • Strategic Investment Management sold 2,414 Arena Pharmaceuticals Inc shares in Q1 2014, an estimated $144K.
  • Strategic Investment Management first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 1 quarter.
  • Strategic Investment Management's Arena Pharmaceuticals Inc position peaked at $144K in Q4 2013.
  • 131 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2014.

Based on Strategic Investment Management's 13F filing for Q1 2014, filed 14 May 2014.